The National Human Genome Research Institute (NHGRI) recently revealed an ambitious effort to capitalize on its flagship genome sequencing program by pumping $416 million into four areas over four years to find the causes of rare inherited diseases and to accelerate the use of genome sequence information in the medical care of patients.